Haverford Trust Company’s Biogen BIIB Stock Holding History

Haverford Trust Company’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-747	Closed	-$217K	–	302
2018 Q2	$217K	Buy	+747	New	+$210K	﹤0.01%	274
2016 Q2	–	Sell	-1,200	Closed	-$312K	–	233
2016 Q1	$312K	Sell	1,200 -29	-2%	-$7.66K	0.01%	192
2015 Q4	$377K	Buy	1,229 +23	+2%	+$6.61K	0.01%	187
2015 Q3	$352K	Buy	1,206 +6	+0.5%	+$1.98K	0.01%	183
2015 Q2	$485K	Hold	1,200	–	–	0.01%	156
2015 Q1	$507K	Hold	1,200	–	–	0.01%	159
2014 Q4	$407K	Hold	1,200	–	–	0.01%	164
2014 Q3	$397K	Hold	1,200	–	–	0.01%	161
2014 Q2	$378K	Hold	1,200	–	–	0.01%	167
2014 Q1	$367K	Sell	1,200 -200	-14%	-$63.5K	0.01%	159
2013 Q4	$391K	Hold	1,400	–	–	0.01%	198
2013 Q3	$337K	Buy	+1,400	New	+$313K	0.01%	154

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Haverford Trust Company's BIIB Position: Q3 2018 in Review

Haverford Trust Company sold out of Biogen (BIIB) in Q3 2018, closing a stake of 747 shares — an estimated $217K sold.

Haverford Trust Company first reported a position in BIIB in Q3 2013 and held it in 12 quarters. The position peaked at $507K in Q1 2015. 1,145 funds tracked by Wall St. Rank hold BIIB as of Q3 2018.

Haverford Trust Company reported no remaining Biogen position as of Q3 2018 after selling out during the quarter.
Haverford Trust Company sold 747 Biogen shares in Q3 2018, an estimated $217K.
Haverford Trust Company first reported a position in Biogen in Q3 2013 and held it in 12 quarters.
Haverford Trust Company's Biogen position peaked at $507K in Q1 2015.
1,145 funds tracked by Wall St. Rank held Biogen as of Q3 2018.

Based on Haverford Trust Company's 13F filing for Q3 2018, filed 8 Nov 2018.